---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-011176"
form_type: "8-K"
ticker: "INBS"
cik: "0001725430"
company_name: "INTELLIGENT BIO SOLUTIONS INC."
filed_at: "2025-05-16T23:59:59+00:00"
generated_at: "2026-05-21T03:25:08.253589+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INBS surpasses 450 accounts; expands fingerprint drug testing into luxury marine, retail, and waste sectors

## Summary
- Over 450 active accounts globally, with 35 new accounts added in fiscal Q3.
- Expanded into luxury marine sector in Europe, retail (major e-commerce) and waste/recycling in Australia.
- Distributor network now includes 18 partners across 19 countries for localized support.
- Plans to introduce a collected testing service to provide flexibility for high-volume customers.

## SEC filing metadata
- accession: 0001641172-25-011176
- form_type: 8-K
- ticker: INBS
- cik: 0001725430
- company_name: INTELLIGENT BIO SOLUTIONS INC.
- filed_at: 2025-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725430/000164117225011176/0001641172-25-011176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725430/000164117225011176/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-011176
- JSON: https://secwatch.observer/filing/0001641172-25-011176.json
- Plain text: https://secwatch.observer/filing/0001641172-25-011176.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.